Sector Chart Actinium Pharmaceuticals, Inc.
Stocks
ATNM
US00507W2061
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
22:04:55 02/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 1.020 USD | +2.46% |
|
0.00% | -25.74% |
| 08-15 | Actinium Pharmaceuticals Expands Manufacturing Capacity for Actimab-A Program | CI |
| 08-15 | Actinium Pharmaceuticals, Inc. Amends Its Investigational New Drug | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 31.3M | - | - | - | ||
| 68.21B | |||||
| 64.25B | |||||
| 26.54B | - | ||||
| 25.61B | - | ||||
| 19.88B |
Select your edition
All financial news and data tailored to specific country editions
